MayBio Biomedical

Beijing, China · Founded 2019 · Privately Held (backing)

Developer of surgical implant products containing human extracellular matrix and collagen designed for medical beauty. MayBio Biomedical is based in Beijing, China and was founded in 2019. Its last reported valuation was $11.4 million in Aug 2020. It has raised $2.9 million.

Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$2.9M
Last round
—

Who backs MayBio Biomedical?

8 investors
InvestorType
Hunan Chasing FundOther
Alwin CapitalVenture capital
Century Golden Resources GroupOther
Beijing New Aerotropolis Fund Management—
Kefu Medical—
Redhill Capital—
Sunz Fund—
ZGC Sci-Tec Leasing—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MayBio Biomedical investors

8 investors are on record for MayBio Biomedical, including Hunan Chasing Fund, Alwin Capital, Century Golden Resources Group and Beijing New Aerotropolis Fund Management.

Free account
More of MayBio Biomedical with a free account
  • ·Watch MayBio Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like MayBio Biomedical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View